title: Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.
abstract: Endogenous airway acidification, as assessed by exhaled breath condensate (EBC) pH, is present in patients with stable COPD. The aim of this study was to measure EBC pH levels in a large cohort of COPD patients and to evaluate associations with functional parameters according to their smoking status.EBC was collected from 161 patients with stable COPD and 112 controls (current and ex-smokers). EBC pH was measured after Argon deaeration and all subjects underwent pulmonary function testing.EBC pH was lower in COPD patients compared to controls [7.21 (7.02, 7.44) vs. 7.50 (7.40, 7.66); p < 0.001] and ex-smokers with COPD had lower EBC pH compared to current smokers [7.16 (6.89, 7.36) vs 7.24 (7.09, 7.54), p = 0.03]. In ex-smokers with COPD, EBC pH was lower in patients with GOLD stage III and IV compared to patients with stage I disease (p = 0.026 and 0.004 respectively). No differences were observed among current smokers with different disease severity. EBC pH levels in ex-smokers were associated with static hyperinflation (as expressed by IC/TLC ratio), air trapping (as expressed by RV/TLC ratio) and diffusing capacity for carbon monoxide, whereas no associations were observed in current smokers.Endogenous airway acidification is related to disease severity and to parameters expressing hyperinflation and air trapping in ex-smokers with COPD. The possible role of EBC pH in COPD needs to be further evaluated in longitudinal studies.
authors: Respiratory Medicine Department, University of Thessaly Medical School, Larissa, Greece.
authors: Andriana I
authors: AI
authors: Papaioannou
authors: Stelios
authors: S
authors: Loukides
authors: Markos
authors: M
authors: Minas
authors: Konstantina
authors: K
authors: Kontogianni
authors: Petros
authors: P
authors: Bakakos
authors: Konstantinos I
authors: KI
authors: Gourgoulianis
authors: Manos
authors: M
authors: Alchanatis
authors: Spyros
authors: S
authors: Papiris
authors: Konstantinos
authors: K
authors: Kostikas
references: Arch Environ Health. 1977 Sep-Oct;32(5):216-26
references: 20855
references: Eur Respir J. 2008 Jan;31(1):70-7
references: 17804442
references: Eur Respir J. 2005 Feb;25(2):269-74
references: 15684290
references: Sci Total Environ. 1989 Aug;84:71-82
references: 2772626
references: Thorax. 2004 Aug;59(8):713-21
references: 15282395
references: Respir Med. 2007 Nov;101(11):2271-8
references: 17693071
references: Am J Respir Crit Care Med. 2000 Mar;161(3 Pt 1):694-9
references: 10712309
references: Eur Respir J. 2005 Nov;26(5):835-45
references: 16264044
references: Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
references: 7663792
references: Eur Respir J. 2008 Aug;32(2):472-86
references: 18669788
references: Respir Res. 2005 Apr 25;6:38
references: 15850494
references: Cough. 2006 Apr 11;2:3
references: 16608520
references: Am J Respir Crit Care Med. 1999 Feb;159(2):557-62
references: 9927373
references: Am J Respir Crit Care Med. 2010 Dec 15;182(12):1492-7
references: 20656939
references: Lung. 2008 Jul-Aug;186(4):263-268
references: 18368450
references: Am J Respir Crit Care Med. 2005 Mar 15;171(6):591-7
references: 15591470
references: Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55
references: 17507545
references: Thorax. 2006 Feb;61(2):115-21
references: 16055612
references: Eur J Clin Invest. 2010 Feb;40(2):103-9
references: 19912318
references: Curr Opin Allergy Clin Immunol. 2009 Feb;9(1):16-22
references: 19532089
references: Eur Respir J. 2006 Apr;27(4):822-32
references: 16585091
references: Am J Respir Crit Care Med. 2006 Feb 15;173(4):366-7
references: 16467175
references: Am J Respir Crit Care Med. 2002 May 15;165(10):1364-70
references: 12016097
references: Am J Respir Crit Care Med. 2002 Jul 1;166(1):105-10
references: 12091179
references: Clin Sci (Lond). 1983 Apr;64(4):449-51
references: 6825413
references: Respir Med. 2009 May;103(5):650-60
references: 19167871
references: Eur Respir J. 2005 Sep;26(3):523-48
references: 16135737